• LOFEXIDINE CHEMBL17860 FDA Approved

    Alternate Names:

    Lofexidine
    2-[1-[2,6-BIS(CHLORANYL)PHENOXY]ETHYL]-4,5-DIHYDRO-1H-IMIDAZOLE
    (-)-2-[1-(2,6-DICHLOROPHENOXY)-ETHYL]-1,3-DIAZACYCLOPENT-2-ENE
    (+)-2-[1-(2,6-DICHLOROPHENOXY)-ETHYL]-1,3-DIAZACYCLOPENT-2-ENE
    1H-IMIDAZOLE,2-[1-(2,6-DICHLOROPHENOXY)ETHYL]-4,5-DIHYDRO-
    A820699
    AB00698543-07
    AB00698543-05
    FT-0627970
    KB-226737
    CAS-31036-80-3
    RP29235
    CCG-220521
    AKOS015900265
    DAP000064
    BDBM50019646
    TOX21_113963
    KSMAGQUYOIHWFS-UHFFFAOYSA-N
    IMI019
    SCHEMBL48960
    DSSTOX_GSID_23221
    DSSTOX_RID_97547
    DSSTOX_CID_3221
    CID30668
    1H-IMIDAZOLE, 2-[1-(2,6-DICHLOROPHENOXY)ETHYL]-4,5-DIHYDRO-
    1H-IMIDAZOLE, 2-(1-(2,6-DICHLOROPHENOXY)ETHYL)-4,5-DIHYDRO- (9CI)
    2-{1-[(2,6-DICHLOROPHENYL)OXY]ETHYL}-4,5-DIHYDRO-1H-IMIDAZOLE
    2-(A-(2,6-DICHLOROPHENOXY)ETHYL)2-IMIDAZOLINE
    D08141
    1H-IMIDAZOLE, 2-(1-(2,6-DICHLOROPHENOXY)ETHYL)-4,5-DIHYDRO-
    LS-79612
    2-(ALPHA-(2,6-DICHLOROPHENOXY)ETHYL) DELTA-2-IMIDAZOLINE
    DB04948
    21498-08-8 (MONO-HYDROCHLORIDE)
    2-IMIDAZOLINE 2-(1-(2,6-DICHLOROPHENOXY)ETHYL)-
    HMS2090C03
    MOLPORT-003-848-405
    2-(1-(2,6-DICHLOROPHENOXY)ETHYL)-4,5-DIHYDRO-1H-IMIDAZOLE
    C11H12CL2N2O
    AC1Q3Q8L
    AC1L1K1D
    CHEBI:51368
    2-[1-(2,6-DICHLOROPHENOXY)ETHYL]-4,5-DIHYDRO-1H-IMIDAZOLE
    LOFEXIDINE (INN)
    LOFEXIDINE [INN:BAN]
    2-(ALPHA-(2,6-DICHLOROPHENOXY)ETHYL)2-IMIDAZOLINE
    LOFEXIDINA [INN-SPANISH]
    LOFEXIDINUM [INN-LATIN]
    31036-80-3
    LOFEXIDINUM
    LOFEXIDINA
    BRITLOFEX
    30668
    NCGC00271513-02
    14774610

    Drug Info:

    Year of Approval not approved by the fda
    Drug Class antihypertensive agents
    Drug Class treatment for opiate withdrawal
    Drug Categories therapeutic uses
    Drug Categories sensory system agents
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories peripheral nervous system agents
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories narcotic antagonists
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories imidazolines
    Drug Categories imidazoles
    Drug Categories hypotensive agents
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories drugs used in opioid dependence
    Drug Categories drugs used in addictive disorders
    Drug Categories chemical actions and uses
    Drug Categories central nervous system agents
    Drug Categories cardiovascular agents
    Drug Categories azoles
    Drug Categories antihypertensive agents
    Drug Categories alpha2 agonists
    Drug Categories adrenergic alpha-agonists
    Drug Categories adrenergic alpha-2 receptor agonists
    Drug Categories adrenergic agonists
    Drug Categories adrenergic agents
    Drug Groups investigational
    Drug Groups approved
    Drug Type small molecule
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications for treatment of opiate withdrawal
    (1 More Sources)